Erythromycin Tablets
formulated to target bacterial infection and indicated to alleviate symptoms of infection by inhibiting bacterial protein synthesis.
Strengths: 250 · 500mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Erythrocin; Erythroped
- Therapeutic class
Macrolide Antibiotic
- Pharmacological class
Macrolide
- Contraindications
hypersensitivity to macrolides; history of QT prolongation
- Minor side effects
nausea; diarrhoea; abdominal pain
- Moderate side effects
vomiting; loss of appetite
- Dosage forms
Tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Abbott
- Onset Time
1–2 hours
- Duration
6 hours
- Storage instructions
Keep container tightly closed.
- Drug interactions
statins; warfarin; astemizole
- Age restrictions
Dose adjustment required for children.
- Pregnancy and breastfeeding
Use only if clearly indicated.
Precautions and warnings
complete the full course; caution with existing heart conditions; monitor for diarrhoea
Serious side effects
hepatotoxicity — requires immediate medical attention; QT prolongation — requires immediate medical attention; anaphylaxis — requires immediate medical attention
Patient summary
formulated to target bacterial infection and indicated to alleviate symptoms of infection by inhibiting bacterial protein synthesis.
Mechanism of action
Erythromycin stops bacterial growth by binding to the 50S ribosomal subunit, interfering with protein synthesis essential for the survival of the bacteria.
Erythromycin Tablets
formulated to target bacterial infection and indicated to alleviate symptoms of infection by inhibiting bacterial protein synthesis.
Editorial Notes
- Active ingredient(s): Erythromycin
- Listed indication(s): Bacterial Infection